What is the recommended prednisone (corticosteroid) dosage for treating urticaria (hives)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Dosing for Urticaria

For acute urticaria, prescribe prednisolone 50 mg daily for 3 days, reserving corticosteroids only for cases not adequately controlled with antihistamines. 1, 2, 3

Treatment Algorithm

First-Line: Antihistamines (Always Start Here)

  • Begin with second-generation H1 antihistamines (cetirizine, loratadine, desloratadine, fexofenadine, levocetirizine) at standard doses for 2-4 weeks 2, 3
  • More than 40% of patients respond to antihistamines alone 2, 3

Second-Line: Updose Antihistamines Before Steroids

  • If inadequate response after 2-4 weeks, increase antihistamine dose up to 4 times the standard dose 4, 2, 3
  • Approximately 75% of patients respond to antihistamine dose escalation 2, 3
  • Do not proceed to corticosteroids until this step has been attempted 3

Third-Line: Short-Course Corticosteroids (Acute Urticaria Only)

When antihistamines fail to control severe acute urticaria:

  • Prednisolone 50 mg daily for 3 days (guideline-recommended regimen) 1, 2, 3
  • Alternative dosing: Prednisone 0.5-1 mg/kg/day (maximum 60 mg/day) until hives resolve 1, 3
  • Lower doses are frequently effective and should be considered to minimize exposure 1, 2, 3
  • Maximum duration: 3-10 days for severe acute exacerbations 1, 2, 3, 5

The evidence strongly supports the 50 mg daily for 3 days regimen from the British Journal of Dermatology and American Academy of Allergy, Asthma, and Immunology guidelines 1, 2, 3. While older literature mentions 40 mg daily 6, the more recent and authoritative guidelines consistently recommend 50 mg for 3 days.

Critical Contraindication: Chronic Urticaria

Long-term oral corticosteroids should NOT be used in chronic urticaria except in very selected cases under regular specialist supervision (Strength of recommendation A). 1, 2, 3, 5

  • This is a firm contraindication due to cumulative toxicity and poor risk-benefit ratio 1, 5
  • Chronic corticosteroids are never appropriate for chronic spontaneous urticaria 1, 2, 3, 5

For Antihistamine-Refractory Chronic Urticaria:

  • Omalizumab 300 mg subcutaneously every 4 weeks (effective in 70% of patients) 4, 3, 5
  • Cyclosporine 4 mg/kg daily for up to 2 months if omalizumab fails (effective in 65-70% of patients) 4, 1, 3, 5
  • Monitor blood pressure and renal function (BUN, creatinine) every 6 weeks with cyclosporine 4, 5

Common Pitfalls to Avoid

  • Never use corticosteroids as first-line treatment when antihistamines are sufficient 3
  • Never continue corticosteroids beyond 3-10 days due to cumulative toxicity 1, 2, 3, 5
  • Never use chronic corticosteroids for chronic spontaneous urticaria - this is the most critical error 1, 2, 3, 5
  • Avoid aspirin and NSAIDs as they can exacerbate urticaria 2, 3
  • Do not use first-generation antihistamines as first-line monotherapy due to sedating properties 2, 3

Emergency Situations

  • For anaphylaxis or severe laryngeal angioedema, administer epinephrine 0.5 mL of 1:1000 (500 µg) intramuscularly immediately 2, 3

References

Guideline

Corticosteroid Use in Urticaria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Urticaria Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Corticosteroid Therapy for Urticaria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

Allergy, asthma & immunology research, 2017

Research

Drug therapy for chronic urticaria.

Clinical reviews in allergy, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.